Evotec banks $10M from its risk-sharing research projects – FierceCRO
0
German contract developer Evotec pocketed €8 million ($10 million) from its ongoing R&D collaborations with Bayer and Johnson & Johnson ($JNJ), capping a big year for the innovative company.
Read more – FierceCRO